As a special factor in pancreatic cancer, ZG16B promotes activation and maturation of DCs through TLR4 signaling pathway to mediate immune system activation; meanwhile, it could also increase and activate MDSCs to benefit tumor formation, showing a double-sided effect on the immunotherapy [30,31]. This evidence concerns the gene ZG16B and pancreatic neoplasm.